FDA — authorised 24 July 2020
- Application: NDA206966
- Marketing authorisation holder: LNHC
- Local brand name: XEGLYZE
- Indication: LOTION — TOPICAL
- Status: approved
🇺🇸 Xeglyze in United States
FDA authorised Xeglyze on 24 July 2020
Marketing authorisations
FDA
- Status: approved
Xeglyze in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Other approved in United States
Frequently asked questions
Is Xeglyze approved in United States?
Yes. FDA authorised it on 24 July 2020; FDA has authorised it.
Who is the marketing authorisation holder for Xeglyze in United States?
LNHC holds the US marketing authorisation.